The Influence of Different Types of Physical Exercise on Immunosenescence in Elderly Persons
NCT ID: NCT04534049
Last Updated: 2022-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
300 participants
INTERVENTIONAL
2011-12-31
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this randomized controlled trial, the effects of resistance exercise (RE) on inflammation and chronic low-grade inflammation (CLIP) will be investigated.
The investigators expect that exercise-induced changes in immunosenescence will be reflected by changes in the various domains of interest: 1) the expression of immunosenescence-related genes in PMBC, in circulating markers of inflammation and in PMBC behaviour following LPS stimulation, 2) the proportion of circulating PMBC showing surface and/or intracellular markers for cell senescence, and 3) markers reflecting alterations at the level of the extracellular matrix.
Additionally, the investigators want to verify whether 1) resistance exercise improves inflammation and immunosenescence in skin tissue, and 2) resistance exercise improves the stress response in skin tissue after an in-vivo inflammatory challenge by saline injection.
The results of this project will allow us to provide new insights in the complex interaction between physical exercise and immunosenescence as well as to present evidence-based guidelines for exercise in elderly persons to counter CLIP
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Immune Function Intervention Trial
NCT00548990
The Effect of Exercise on Myokine Production in Aging Persons
NCT05571709
Exercise and COVID-19 Viral T-cell Immunity
NCT05019456
Resistance-type Exercise Training in the Older Population
NCT04999501
Innate Immune Response to (An)Aerobic Exercise in Rowing Athletes
NCT01893762
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intensive strength training (IST)
Intensive Strength Training (IST)
Strength Endurance training (SET)
Strength Endurance Training (SET)
Flexibility training (FT)
Flexibility Training (FT)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intensive Strength Training (IST)
Strength Endurance Training (SET)
Flexibility Training (FT)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged ≥65yrs.
Exclusion Criteria
* Presenting contra-indications for any of the exercise interventions;
* Cognitive impairment (unable to understand or execute the test/exercise instructions due to cognitive impairment (MMSE\<24/30));
* Presenting physical disability;
* Using anti-inflammatory and/or immunosuppressive medication
* Presenting an acute inflammatory condition (CRP \>10mg/L)
* use of medications that cannot be temporarily interrupted for this study:
* medication that suppresses allergic reaction,
* Anticoagulation,
* Treatment with cortisone creams, calcineurin inhibitor creams (Elidel, Protopic) within 7 days before the first visit,
* Treatment with the following medication within 5 half-lives for the first visit: systemic immunosuppressive / immunomodulating medications (e.g. methotrexate (Ledertrexat), cyclosporine (Neoral), azathioprine (Imuran), mycomofetil phenolate (Cellcept)), Cortisone tablets (eg Medrol) (except use of cortisone in the form of nasal spray, puffer, eye drops), Targeted biological treatment (monoclonal antibodies or inhibitors, eg Dupixent),
* undergoing or have undergone allergen-specific immunotherapy,
* participating in another interventional clinical study for atopic dermatitis,
* showing inflammatory skin diseases (e.g. atopic eczema, psoriasis).
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vrije Universiteit Brussel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Ivan Bautmans
Prof. dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vrije Universiteit Brussel
Jette, Brussels Capital, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FRIA_SPRINT_1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.